XML 139 R128.htm IDEA: XBRL DOCUMENT v3.23.3
Warrants (Details) - USD ($)
 1 Months Ended 9 Months Ended
Dec. 08, 2020
Nov. 09, 2007
Jan. 20, 2005
Sep. 30, 2023
Apr. 19, 2016
Warrants [Line Items]          
Stock issued during period, shares 9,489,800   1,720,087    
Common stock price (in Dollars per share)         $ 0.001
Gross proceeds from stock issuance (in Dollars)     $ 17,000,000    
Warrants issued to purchase common stock 3,795,920        
Warrants exercise price (in Dollars per share) $ 6.46        
Gross proceeds from private placement (in Dollars)       $ 70,000,000  
Offering expenses (in Dollars) $ 3,810,000     $ 5,000,000  
Warrant issued       9,092,499  
Warrant outstanding       9,092,499  
Private Placement [Member]          
Warrants [Line Items]          
Offering expenses (in Dollars)   $ 819,000   $ 5,000,000  
Common Stock [Member] | IPO [Member]          
Warrants [Line Items]          
Stock issued during period, shares 9,489,800        
Common stock price (in Dollars per share) $ 5.18        
Gross proceeds from stock issuance (in Dollars) $ 49,000,000        
Common Stock [Member] | Securities Purchase Agreement [Member]          
Warrants [Line Items]          
Warrants exercise price (in Dollars per share) $ 6.475        
Placement Agent Warrants [Member]          
Warrants [Line Items]          
Warrants issued to purchase common stock 379,592     446,999  
Warrants exercise price (in Dollars per share) $ 6.475     $ 9.204  
Securities Purchase Agreement [Member]          
Warrants [Line Items]          
Warrants, description       On February 8, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued in a registered direct offering, an aggregate of 8,939,976 shares of common stock of the Company at a per share purchase price of $7.83. In addition, the Company issued to the investors (i) in a concurrent private placement, the Series A-1 warrants to purchase a total of 4,469,988 shares of common stock, at a per share exercise price of $7.67 and exercisable for 42 months from the date of issuance; (ii) in the registered direct offering, the Series B warrants to purchase a total of 4,469,988 shares of common stock, at a per share exercise price of $7.83 and exercisable for 90 days from the date of issuance; and (iii) in the registered direct offering, the Series A-2 warrants to purchase up to 2,234,992 shares of common stock, at a per share exercise price of $7.67 and exercisable for 45 months from the date of issuance.